Skip to content

Creation of an Algorithm for the Personalisation of Pedalling Exercises

Personalisation of Exercise by Muscle Modulation, Step 1: Construction and Validation of an Algorithm for Personalisation for Pedalling Exercises

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03280875
Acronym
EXOMODE
Enrollment
133
Registered
2017-09-13
Start date
2017-05-02
Completion date
2021-05-13
Last updated
2021-07-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging

Brief summary

The aim of the EXO-MODE project is to develop an innovative algorithm for the personalisation of Concentric and / or Eccentric training programmes adapted to the individual to improve the efficiency and tolerance. This algorithm will make it possible to personalise trainings programmes according to the different profiles of subjects, determined on the basis of their personal characteristics (age, sex, comorbidities), their exercise capacity and muscle performance, their level of motivation and their perception of the workload, and of the principal objective of the training programme. The final goal is to develop a tool to allow elderly populations to exercise more easily and more effectively.

Interventions

OTHERpedalling exercises

pedalling exercises on a bicycle ergometer

Sponsors

Centre Hospitalier Universitaire Dijon
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Subject able to understand simple instructions and to provide consent * Men or women aged 18 to 75 years old. * Subjects who engage in moderate physical activity (Level 1 or 2 defined by the recommendations for the classification of subjects during performance studies) \[2\].

Exclusion criteria

* Persons without national health insurance cover, * Cardio-respiratory failure, coronaropathy, severe obstructive cardiomyopathy, * Recent history of venous thromboembolism (previous 3 months), * Any medical disorder that could have a major impact on functional capacities (examples: non-stabilised metabolic disorders, such as progressive renal failure, severe asthenia related to a non-stabilised disease, such as neoplasia, systemic disease…), * Physical disability affecting the lower limbs or the pelvis that could impair or prevent exercise on a cycle ergometer, whether neurological (central or peripheral), arterial (i particular, arteriopathy of the lower limbs with a systolic index \< 0.6) or orthopaedic (degenerative or inflammatory rheumatism). * Pregnant or breast-feeding women

Design outcomes

Primary

MeasureTime frame
Preliminary phase: level of perception of effort dissociated from the pain feltthrough study phase completion, an average of 3 months
Phase 1:level of pain measured by visual analog scalethrough study phase completion, an average of 9 months

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026